Koninklijke Philips Operating Margin 2010-2025 | PHG
Current and historical operating margin for Koninklijke Philips (PHG) over the last 10 years. The current operating profit margin for Koninklijke Philips as of March 31, 2025 is 7.24%.
| Koninklijke Philips Operating Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Operating Income | Operating Margin |
| 2025-03-31 | $18.81B | $1.66B | 8.80% |
| 2024-09-30 | $18.97B | $0.87B | 4.57% |
| 2024-06-30 | $18.60B | $0.51B | 2.73% |
| 2023-06-30 | $18.89B | $-0.27B | -1.43% |
| 2023-03-31 | $18.85B | $-0.26B | -1.38% |
| 2022-06-30 | $19.63B | $0.76B | 3.86% |
| 2021-06-30 | $20.30B | $1.10B | 5.42% |
| 2020-06-30 | $19.93B | $1.28B | 6.41% |
| 2019-06-30 | $22.93B | $1.93B | 8.40% |
| 2018-06-30 | $24.26B | $2.07B | 8.54% |
| 2017-06-30 | $25.77B | $2.14B | 8.31% |
| 2016-12-31 | $27.13B | $2.08B | 7.68% |
| 2016-09-30 | $27.08B | $1.36B | 5.02% |
| 2016-06-30 | $26.99B | $1.20B | 4.46% |
| 2016-03-31 | $26.98B | $1.17B | 4.32% |
| 2015-12-31 | $26.92B | $1.10B | 4.09% |
| 2015-09-30 | $26.06B | $0.93B | 3.55% |
| 2015-06-30 | $26.93B | $0.42B | 1.57% |
| 2015-03-31 | $27.58B | $0.49B | 1.79% |
| 2014-12-31 | $28.44B | $0.65B | 2.27% |
| 2014-09-30 | $30.72B | $1.61B | 5.23% |
| 2014-06-30 | $30.80B | $2.34B | 7.60% |
| 2014-03-31 | $30.92B | $2.55B | 8.25% |
| 2013-12-31 | $30.99B | $2.65B | 8.54% |
| 2013-09-30 | $31.41B | $1.78B | 5.66% |
| 2013-06-30 | $31.96B | $1.91B | 5.97% |
| 2013-03-31 | $31.77B | $1.45B | 4.56% |
| 2012-12-31 | $32.19B | $1.63B | 5.07% |
| 2012-09-30 | $31.35B | $1.50B | 4.78% |
| 2012-06-30 | $30.80B | $0.95B | 3.10% |
| 2012-03-31 | $31.11B | $1.08B | 3.48% |
| 2011-12-31 | $31.33B | $1.33B | 4.24% |
| 2011-09-30 | $32.59B | $2.35B | 7.21% |
| 2011-06-30 | $33.09B | $2.78B | 8.41% |
| 2011-03-31 | $33.49B | $2.97B | 8.85% |
| 2010-12-31 | $33.77B | $2.66B | 7.87% |
| 2010-09-30 | $34.44B | $3.94B | 11.44% |
| 2010-06-30 | $34.60B | $3.71B | 10.73% |
| 2010-03-31 | $34.14B | $2.13B | 6.23% |
| 2009-12-31 | $32.91B | $1.35B | 4.10% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $24.092B | $19.503B |
| Koninklijke Philips N.V. is the parent company of the Philips Group. The company realigned its three reporting operations into Diagnosis & Treatment businesses consists of Diagnostic Imaging, Ultrasound, Image-Guided Therapy and Enterprise Diagnostic Informatics businesses. Connected Care business comprises the Monitoring & Analytics, Therapeutic Care, Population Health Management, Sleep & Respiratory Care and Connected Care Informatics businesses. Personal Health business consists of the Oral Healthcare, Mother & Child Care and Personal Care. Other consists of Innovation, Emerging Businesses, IP Royalties, Central costs and Other. Notably, Philips completed the divestiture of Domestic Appliances business. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $218.750B | 25.66 |
| Boston Scientific (BSX) | United States | $152.620B | 38.21 |
| Stryker (SYK) | United States | $150.824B | 31.54 |
| EssilorLuxottica (ESLOY) | France | $131.932B | 0.00 |
| Medtronic (MDT) | Ireland | $117.545B | 16.66 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.596B | 0.00 |
| Haleon (HLN) | United Kingdom | $43.351B | 24.74 |
| ResMed (RMD) | United States | $39.208B | 29.45 |
| GE HealthCare Technologies (GEHC) | United States | $35.024B | 16.63 |
| Agilent Technologies (A) | United States | $33.005B | 21.52 |
| Terumo (TRUMY) | Japan | $23.645B | 30.71 |
| Insulet (PODD) | United States | $20.097B | 78.89 |
| Zimmer Biomet Holdings (ZBH) | United States | $19.096B | 12.26 |
| Baxter (BAX) | United States | $14.117B | 10.54 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.547B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $10.417B | 0.00 |
| Demant (WILYY) | Denmark | $8.633B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.680B | 23.25 |
| Lantheus Holdings (LNTH) | United States | $5.005B | 12.62 |
| Perrigo (PRGO) | Ireland | $3.788B | 9.60 |
| Prestige Consumer Healthcare (PBH) | United States | $3.776B | 16.87 |
| Haemonetics (HAE) | United States | $3.565B | 16.24 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.397B | 28.23 |
| ICU Medical (ICUI) | United States | $3.107B | 22.91 |
| LeMaitre Vascular (LMAT) | United States | $1.816B | 40.60 |
| QuidelOrtho (QDEL) | United States | $1.727B | 11.88 |
| AtriCure (ATRC) | United States | $1.454B | 0.00 |
| Acuren (TIC) | United States | $1.435B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.279B | 12.99 |
| Green Thumb Industries (GTBIF) | United States | $1.243B | 27.96 |
| Phibro Animal Health (PAHC) | United States | $1.185B | 15.15 |
| Neogen (NEOG) | United States | $1.090B | 13.94 |
| BioLife Solutions (BLFS) | United States | $1.024B | 0.00 |
| InMode (INMD) | Israel | $0.911B | 9.18 |
| Kestra Medical Technologies (KMTS) | United States | $0.874B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.791B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.784B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.644B | 0.00 |
| Owens & Minor (OMI) | United States | $0.626B | 5.19 |
| Evolus (EOLS) | United States | $0.617B | 0.00 |
| CeriBell (CBLL) | United States | $0.561B | 0.00 |
| Valneva SE (VALN) | France | $0.530B | 0.00 |
| ZimVie (ZIMV) | United States | $0.522B | 23.71 |
| Surmodics (SRDX) | United States | $0.456B | 0.00 |
| SNDL (SNDL) | Canada | $0.431B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.315B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.312B | 11.48 |
| Cresco Labs (CRLBF) | United States | $0.307B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.303B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.298B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.284B | 84.17 |
| Quanterix (QTRX) | United States | $0.275B | 0.00 |
| Cerus (CERS) | United States | $0.273B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.258B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.257B | 21.67 |
| Canopy Growth (CGC) | Canada | $0.256B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.234B | 0.00 |
| Brainsway (BWAY) | Israel | $0.229B | 60.50 |
| Biote (BTMD) | United States | $0.225B | 6.34 |
| Verano Holdings (VRNOF) | United States | $0.220B | 0.00 |
| Omeros (OMER) | United States | $0.219B | 0.00 |
| Organigram Global (OGI) | Canada | $0.208B | 0.00 |
| High Tide (HITI) | Canada | $0.195B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.183B | 14.93 |
| TriSalus Life Sciences (TLSI) | United States | $0.170B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.153B | 0.00 |
| Exagen (XGN) | United States | $0.148B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.124B | 15.32 |
| TerrAscend (TSNDF) | Canada | $0.112B | 0.00 |
| Jin Medical (ZJYL) | China | $0.100B | 0.00 |
| Fonar (FONR) | United States | $0.099B | 12.77 |
| MacroGenics (MGNX) | United States | $0.097B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.096B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.087B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.086B | 0.00 |
| Apyx Medical (APYX) | United States | $0.085B | 0.00 |
| Veru (VERU) | United States | $0.084B | 0.00 |
| Safety Shot (SHOT) | United States | $0.081B | 0.00 |
| Zynex (ZYXI) | United States | $0.074B | 0.00 |
| InterCure (INCR) | Israel | $0.072B | 0.00 |
| Agape ATP (ATPC) | $0.068B | 0.00 | |
| Cytosorbents (CTSO) | United States | $0.063B | 0.00 |
| ImmuCell (ICCC) | United States | $0.062B | 0.00 |
| United-Guardian (UG) | United States | $0.044B | 15.11 |
| Rockwell Medical (RMTI) | United States | $0.039B | 0.00 |
| Modular Medical (MODD) | United States | $0.038B | 0.00 |
| Nephros (NEPH) | United States | $0.037B | 50.14 |
| Allurion Technologies (ALUR) | United States | $0.024B | 0.00 |
| INLIF (INLF) | $0.015B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.015B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.013B | 0.00 |
| Senestech (SNES) | United States | $0.013B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.012B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| Sharps Technology (STSS) | United States | $0.006B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |